These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2169003)

  • 1. Nuclear morphometry as a predictor of response to therapy in Wilms tumor: a preliminary report.
    Partin AW; Walsh AC; Epstein JI; Leventhal BG; Gearhart JP
    J Urol; 1990 Oct; 144(4):952-4. PubMed ID: 2169003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of disease-free survival after therapy in Wilms' tumor using nuclear morphometric techniques.
    Partin AW; Yoo JK; Crooks D; Epstein JI; Beckwith JB; Gearhart JP
    J Pediatr Surg; 1994 Mar; 29(3):456-60. PubMed ID: 8201520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of nuclear morphometry to predict prognosis in pediatric urologic malignancies: a review.
    Partin AW; Gearhart JP; Leonard MP; Leventhal BG; Yoo JK; Crooks D; Epstein JI; Beckwith JB
    Med Pediatr Oncol; 1993; 21(3):222-9. PubMed ID: 8383283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of nuclear morphometry to predict response to therapy in Wilms' tumor.
    Gearhart JP; Partin AW; Leventhal B; Beckwith JB; Epstein JI
    Cancer; 1992 Feb; 69(3):804-8. PubMed ID: 1309682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nuclear morphometric analysis of metastasis in Wilms' tumor after multimodal therapy: comparison with primary tumor.
    Gearhart JP; Willmann JR; Beckwith JB; Epstein J; Partin AW
    Urology; 1995 Jan; 45(1):119-23. PubMed ID: 7817463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuclear morphometry and prognosis in favorable histology Wilms' tumor: A prospective reevaluation.
    Breslow NE; Partin AW; Lee BR; Guthrie KA; Beckwith JB; Green DM
    J Clin Oncol; 1999 Jul; 17(7):2123-6. PubMed ID: 10561267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Results of the SIOP 93-01/GPOH trial and study for the treatment of patients with unilateral nonmetastatic Wilms Tumor.
    Reinhard H; Semler O; Bürger D; Bode U; Flentje M; Göbel U; Gutjahr P; Leuschner I; Maass E; Niggli F; Scheel-Walter HG; Stöckle M; Thüroff JW; Tröger J; Weirich A; von Schweinitz D; Zoubek A; Graf N
    Klin Padiatr; 2004; 216(3):132-40. PubMed ID: 15175957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relapse of unilateral favorable histology Wilms' tumor: significant clinicopathological factors.
    Aoba T; Urushihara N; Fukumoto K; Furuta S; Fukuzawa H; Mitsunaga M; Watanabe K; Yamoto M; Miyake H; Koyama M; Iwabuchi H; Koike J; Tatsunami S; Wakisaka M; Kitagawa H
    J Pediatr Surg; 2012 Dec; 47(12):2210-5. PubMed ID: 23217878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B7-h1 as a biomarker for therapy failure in patients with favorable histology Wilms tumor.
    Routh JC; Grundy PE; Anderson JR; Retik AB; Kurek KC
    J Urol; 2013 Apr; 189(4):1487-92. PubMed ID: 23154206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The current management of bilateral Wilms tumor.
    Kay R; Tank E
    J Urol; 1986 May; 135(5):983-5. PubMed ID: 3007787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prognostic significance of blastemal predominant histology in initially resected Wilms' tumors: a report from the Study Group for Pediatric Solid Tumors in the Kyushu Area, Japan.
    Kinoshita Y; Suminoe A; Inada H; Yagi M; Yanai F; Zaizen Y; Nishi M; Inomata Y; Kawakami K; Matsufuji H; Suenobu S; Handa N; Kohashi K; Oda Y; Hara T; Taguchi T
    J Pediatr Surg; 2012 Dec; 47(12):2205-9. PubMed ID: 23217877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nuclear shape analysis for assessment of prognosis in renal cell carcinoma.
    Murphy GF; Partin AW; Maygarden SJ; Mohler JL
    J Urol; 1990 Jun; 143(6):1103-7. PubMed ID: 2342168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bilateral Wilms tumor.
    Blute ML; Kelalis PP; Offord KP; Breslow N; Beckwith JB; D'Angio GJ
    J Urol; 1987 Oct; 138(4 Pt 2):968-73. PubMed ID: 2821293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Wilms' tumor. Its multidisciplinary management].
    Rivera Luna R; Martínez Guerra G; Ruano Aguilar J; Cárdenas Cardoz R; Lanche Guevara T
    Gac Med Mex; 1992; 128(2):97-104; discussion 104-5. PubMed ID: 1338780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Wilms' tumor].
    Graf N
    Praxis (Bern 1994); 1996 Jun; 85(23):753-61. PubMed ID: 8693243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced therapy for Wilms' tumor: analysis of treatment results from a single institution.
    Wilimas JA; Douglass EC; Lewis S; Fairclough D; Fullen G; Parham D; Kumar AP; Hustu HO; Fleming I
    J Clin Oncol; 1988 Oct; 6(10):1630-5. PubMed ID: 2845012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved survival for children with anaplastic Wilms' tumors.
    Corey SJ; Andersen JW; Vawter GF; Lack EE; Sallan SE
    Cancer; 1991 Sep; 68(5):970-4. PubMed ID: 1655221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Results of Wilms' tumor trial (WT-99) in Shanghai children's medical center].
    Tang JY; Pan C; Xu M; Xue HL; Chen J; Zhao HL; Gu LL; Wang YP
    Zhonghua Er Ke Za Zhi; 2003 Feb; 41(2):131-4. PubMed ID: 14759320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relapse-associated variables in stage I favorable histology Wilms' tumor. A report of the National Wilms' Tumor Study.
    Weeks DA; Beckwith JB; Luckey DW
    Cancer; 1987 Sep; 60(6):1204-12. PubMed ID: 3040208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Argyrophilic nucleolar organizer regions in Wilms' tumors and related lesions: a histologic and chromosomal correlation.
    Mourad WA; Lavallee-Grey M; Pappenhausen P; Essig YP; Rowlands DT
    Mod Pathol; 1991 Mar; 4(2):247-52. PubMed ID: 1646458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.